Correction: Primary Care COPD Patients Compared with Large Pharmaceutically-Sponsored COPD Studies: An UNLOCK Validation Study

Citation: The PLOS ONE Staff (2014) Correction: Primary Care COPD Patients Compared with Large Pharmaceutically-Sponsored COPD Studies: An UNLOCK Validation Study. PLoS ONE 9(5): e98725. doi:10.1371/journal.pone.0098725 Published May 23, 2014 Copyright: 2014 The PLOS ONE Staff. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Table 7. Percentage of patients remaining after introduction of different selection criteria used in six large COPD studies.

• Publication year

  2014

• Venue

  PLoS ONE

• Publication date

  2014-05-23

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1371/journal.pone.0098725PMCID 4032341
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Primary Care COPD Patients Compared with Large Pharmaceutically-Sponsored COPD Studies: An UNLOCK Validation Study

  2014cited by this paper
• RECODE: Design and baseline results of a cluster randomized trial on cost-effectiveness of integrated COPD management in primary care

  2013cited by this paper
• Putting health status guided COPD management to the test: protocol of the MARCH study

  2013cited by this paper
• Overtreatment of COPD with Inhaled Corticosteroids - Implications for Safety and Costs: Cross-Sectional Observational Study

  2013cited by this paper
• Primary care physician perceptions on the diagnosis and management of chronic obstructive pulmonary disease in diverse regions of the world

  2012cited by this paper
• Clinical COPD Questionnaire score (CCQ) and mortality

  2012cited by this paper
• Assessing health status in COPD. A head-to-head comparison between the COPD assessment test (CAT) and the clinical COPD questionnaire (CCQ)

  2012cited by this paper
• The Dyspnoea, Obstruction, Smoking, Exacerbation (DOSE) index is predictive of mortality in COPD.

  2012cited by this paper
• Controversies in treatment of chronic obstructive pulmonary disease.

  2011cited by this paper
• Barriers to adherence to chronic obstructive pulmonary disease guidelines by primary care physicians

  2011cited by this paper
• Inappropriate Overuse of Inhaled Corticosteroids for COPD Patients: Impact on Health Costs and Health Status

  2011cited by this paper
• Tiotropium versus salmeterol for the prevention of exacerbations of COPD.

  2011cited by this paper
• UNLOCK: Uncovering and Noting Long-term Outcomes in COPD to enhance knowledge.

  2010cited by this paper
• Sex bias in trials and treatment must end

  2010cited by this paper
• Susceptibility to exacerbation in chronic obstructive pulmonary disease.

  2010cited by this paper
• Sex differences in mortality and clinical expressions of patients with chronic obstructive pulmonary disease. The TORCH experience.

  2010cited by this paper
• Characterisation of COPD heterogeneity in the ECLIPSE cohort

  2010cited by this paper
• Integrated disease management improves one-year quality of life in primary care COPD patients: a controlled clinical trial.

  2009cited by this paper
• Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial.

  2009cited by this paper
• Efficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled TORCH study

  2009cited by this paper
• A 4-year trial of tiotropium in chronic obstructive pulmonary disease.

  2008cited by this paper
• Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE)

  2008cited by this paper
• Accuracy of diagnostic registers and management of chronic obstructive pulmonary disease: the Devon primary care audit

  2008cited by this paper
• Practice patterns in the management of chronic obstructive pulmonary disease in primary practice: the CAGE study.

  2008cited by this paper
• Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study.

  2008cited by this paper
• Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease.

  2007cited by this paper
• International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study.

  2007cited by this paper
• External validity of randomized controlled trials in COPD.

  2007cited by this paper
• Use of spirometry and patterns of prescribing in COPD in primary care.

  2007cited by this paper
• Factors That Can Affect the External Validity of Randomised Controlled Trials

  2006cited by this paper
• National Survey of Guideline-Compliant COPD Management Among Pneumologists and Primary Care Physicians

  2006cited by this paper
• Clinical Practice Guidelines for Chronic Obstructive Pulmonary Disease: A Review and Comparison of Current Resources

  2006cited by this paper
• How representative are clinical study patients with asthma or COPD for a larger "real life" population of patients with obstructive lung disease?

  2005cited by this paper
• Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study

  2005cited by this paper
• Impact of preventing exacerbations on deterioration of health status in COPD

  2004cited by this paper
• [Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease].

  2004cited by this paper
• The TORCH (TOwards a Revolution in COPD Health) survival study protocol

  2004cited by this paper
• Health and Quality of Life Outcomes

  2003cited by this paper
• Disease severity and the effect of fluticasone propionate on chronic obstructive pulmonary disease exacerbations

  2003cited by this paper
• Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial

  2000cited by this paper
• Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease

  1999cited by this paper
• The St George's Respiratory Questionnaire.

  1991cited by this paper

• No citing papers are available for this paper.